Concepts (283)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oncolytic Virotherapy | 12 | 2024 | 83 | 6.480 |
Why?
|
| Adenoviridae | 17 | 2024 | 605 | 5.440 |
Why?
|
| Oncolytic Viruses | 9 | 2024 | 71 | 4.260 |
Why?
|
| Immunotherapy, Adoptive | 9 | 2024 | 789 | 2.740 |
Why?
|
| Genetic Vectors | 15 | 2020 | 924 | 2.430 |
Why?
|
| Neoplasms | 8 | 2024 | 2750 | 1.800 |
Why?
|
| Genetic Therapy | 10 | 2023 | 662 | 1.640 |
Why?
|
| Transgenes | 9 | 2015 | 326 | 1.630 |
Why?
|
| Antibodies, Bispecific | 2 | 2024 | 35 | 1.550 |
Why?
|
| T-Lymphocytes | 8 | 2024 | 1677 | 1.330 |
Why?
|
| Interleukin-12 | 4 | 2021 | 114 | 1.160 |
Why?
|
| Helper Viruses | 5 | 2021 | 45 | 1.060 |
Why?
|
| Receptors, Antigen, T-Cell | 6 | 2024 | 478 | 1.020 |
Why?
|
| Sex Determination Processes | 1 | 2024 | 12 | 0.970 |
Why?
|
| Moths | 1 | 2024 | 22 | 0.960 |
Why?
|
| Insect Proteins | 1 | 2024 | 98 | 0.930 |
Why?
|
| Sarcoidosis | 2 | 2022 | 63 | 0.920 |
Why?
|
| Simplexvirus | 3 | 2009 | 99 | 0.900 |
Why?
|
| B7-H1 Antigen | 4 | 2021 | 98 | 0.880 |
Why?
|
| Janus Kinases | 1 | 2023 | 31 | 0.850 |
Why?
|
| Immunity, Innate | 5 | 2023 | 374 | 0.840 |
Why?
|
| Xenograft Model Antitumor Assays | 9 | 2024 | 876 | 0.840 |
Why?
|
| Myeloid Differentiation Factor 88 | 3 | 2015 | 82 | 0.800 |
Why?
|
| Combined Modality Therapy | 4 | 2024 | 1240 | 0.800 |
Why?
|
| Hematologic Neoplasms | 1 | 2024 | 272 | 0.740 |
Why?
|
| Myocarditis | 1 | 2022 | 119 | 0.730 |
Why?
|
| Aortic Valve Stenosis | 2 | 2021 | 325 | 0.720 |
Why?
|
| Ecosystem | 1 | 2021 | 76 | 0.720 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2020 | 16 | 0.700 |
Why?
|
| Animals | 31 | 2024 | 33693 | 0.660 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2021 | 154 | 0.650 |
Why?
|
| Receptor, ErbB-2 | 6 | 2024 | 495 | 0.650 |
Why?
|
| Antibodies, Monoclonal | 3 | 2021 | 1015 | 0.640 |
Why?
|
| Dependovirus | 4 | 2021 | 119 | 0.620 |
Why?
|
| Amino Acids | 1 | 2021 | 651 | 0.610 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2023 | 543 | 0.600 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2017 | 769 | 0.590 |
Why?
|
| Mice | 25 | 2024 | 17469 | 0.570 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2021 | 651 | 0.570 |
Why?
|
| Gene Silencing | 2 | 2010 | 237 | 0.570 |
Why?
|
| Adoptive Transfer | 1 | 2018 | 236 | 0.570 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 3283 | 0.550 |
Why?
|
| Head and Neck Neoplasms | 2 | 2021 | 482 | 0.550 |
Why?
|
| Aorta, Thoracic | 1 | 2020 | 516 | 0.500 |
Why?
|
| Chromatin | 4 | 2024 | 552 | 0.490 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 687 | 0.480 |
Why?
|
| Factor X | 1 | 2012 | 4 | 0.420 |
Why?
|
| Gene Expression | 5 | 2017 | 1569 | 0.410 |
Why?
|
| Interferon Type I | 1 | 2013 | 107 | 0.400 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2011 | 22 | 0.380 |
Why?
|
| Humans | 32 | 2024 | 122997 | 0.370 |
Why?
|
| Gene Transfer Techniques | 5 | 2021 | 355 | 0.350 |
Why?
|
| Liver | 6 | 2015 | 1727 | 0.350 |
Why?
|
| Signal Transduction | 3 | 2024 | 4507 | 0.350 |
Why?
|
| Histones | 2 | 2024 | 528 | 0.340 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 538 | 0.340 |
Why?
|
| Herpesvirus 1, Human | 2 | 2008 | 26 | 0.340 |
Why?
|
| Aortic Valve | 3 | 2021 | 428 | 0.330 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2013 | 239 | 0.320 |
Why?
|
| Female | 16 | 2024 | 65309 | 0.320 |
Why?
|
| Immediate-Early Proteins | 1 | 2009 | 58 | 0.310 |
Why?
|
| Tumor Burden | 2 | 2021 | 230 | 0.310 |
Why?
|
| Heart Failure | 1 | 2021 | 2123 | 0.310 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 287 | 0.310 |
Why?
|
| Transduction, Genetic | 4 | 2016 | 277 | 0.290 |
Why?
|
| Male | 14 | 2024 | 59901 | 0.290 |
Why?
|
| STAT1 Transcription Factor | 1 | 2007 | 69 | 0.280 |
Why?
|
| Dendritic Cells | 2 | 2024 | 402 | 0.280 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2009 | 351 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 8 | 2024 | 4342 | 0.260 |
Why?
|
| Mice, Knockout | 9 | 2024 | 3710 | 0.250 |
Why?
|
| Cytokines | 3 | 2023 | 1280 | 0.250 |
Why?
|
| Plasmids | 1 | 2006 | 511 | 0.240 |
Why?
|
| Serotonergic Neurons | 1 | 2024 | 21 | 0.240 |
Why?
|
| Receptors, Serotonin | 1 | 2024 | 42 | 0.240 |
Why?
|
| Chorioallantoic Membrane | 1 | 2024 | 12 | 0.240 |
Why?
|
| Transcription, Genetic | 2 | 2024 | 1695 | 0.240 |
Why?
|
| Immunoglobulin A | 2 | 2024 | 197 | 0.230 |
Why?
|
| CD3 Complex | 1 | 2024 | 82 | 0.230 |
Why?
|
| Clinical Studies as Topic | 2 | 2021 | 10 | 0.230 |
Why?
|
| Liver Abscess | 1 | 2023 | 12 | 0.230 |
Why?
|
| Mice, Inbred NOD | 2 | 2024 | 285 | 0.220 |
Why?
|
| Serotonin | 1 | 2024 | 222 | 0.220 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 18 | 0.220 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 23 | 0.210 |
Why?
|
| Blastocyst | 1 | 2023 | 76 | 0.210 |
Why?
|
| RNA Interference | 1 | 2024 | 496 | 0.210 |
Why?
|
| ErbB Receptors | 1 | 2004 | 284 | 0.210 |
Why?
|
| Immunotherapy | 2 | 2024 | 654 | 0.200 |
Why?
|
| Technetium Tc 99m Sestamibi | 1 | 2022 | 25 | 0.200 |
Why?
|
| Mice, Nude | 3 | 2017 | 691 | 0.200 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 323 | 0.200 |
Why?
|
| Adaptive Immunity | 2 | 2015 | 88 | 0.200 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2022 | 104 | 0.190 |
Why?
|
| Escherichia coli Infections | 1 | 2023 | 191 | 0.190 |
Why?
|
| Retrospective Studies | 5 | 2022 | 15930 | 0.190 |
Why?
|
| Mitral Valve Prolapse | 1 | 2021 | 28 | 0.190 |
Why?
|
| Interferon-alpha | 1 | 2023 | 221 | 0.190 |
Why?
|
| Radiopharmaceuticals | 1 | 2022 | 156 | 0.190 |
Why?
|
| A549 Cells | 2 | 2021 | 44 | 0.190 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2022 | 87 | 0.190 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2022 | 135 | 0.190 |
Why?
|
| Intestines | 2 | 2024 | 571 | 0.180 |
Why?
|
| Single-Chain Antibodies | 1 | 2021 | 41 | 0.180 |
Why?
|
| Viral Tropism | 2 | 2021 | 34 | 0.180 |
Why?
|
| Coculture Techniques | 1 | 2021 | 234 | 0.180 |
Why?
|
| Inflammation | 2 | 2022 | 1400 | 0.180 |
Why?
|
| Histone Deacetylases | 2 | 2013 | 115 | 0.180 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 287 | 0.170 |
Why?
|
| Amino Acid Sequence | 1 | 2024 | 2698 | 0.170 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2021 | 119 | 0.170 |
Why?
|
| Hyaluronan Receptors | 1 | 2020 | 66 | 0.170 |
Why?
|
| Dysbiosis | 1 | 2021 | 120 | 0.170 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2019 | 8 | 0.170 |
Why?
|
| Mammals | 1 | 2021 | 262 | 0.170 |
Why?
|
| Sinus of Valsalva | 1 | 2020 | 36 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 996 | 0.170 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2021 | 155 | 0.160 |
Why?
|
| Molecular Sequence Data | 1 | 2024 | 3871 | 0.160 |
Why?
|
| Fibroblasts | 3 | 2010 | 877 | 0.160 |
Why?
|
| Mice, SCID | 1 | 2020 | 571 | 0.160 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 1581 | 0.160 |
Why?
|
| RNA, Messenger | 3 | 2011 | 2820 | 0.160 |
Why?
|
| Computed Tomography Angiography | 1 | 2020 | 195 | 0.150 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 649 | 0.150 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2021 | 192 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2023 | 532 | 0.150 |
Why?
|
| DNA Primers | 2 | 2009 | 661 | 0.150 |
Why?
|
| Antibodies, Neoplasm | 1 | 2017 | 58 | 0.150 |
Why?
|
| Aged | 5 | 2022 | 19035 | 0.150 |
Why?
|
| Coronary Angiography | 1 | 2020 | 417 | 0.140 |
Why?
|
| Lymphocyte Transfusion | 1 | 2017 | 57 | 0.140 |
Why?
|
| Crime | 1 | 2017 | 25 | 0.140 |
Why?
|
| Bacteria | 1 | 2021 | 483 | 0.140 |
Why?
|
| Hep G2 Cells | 1 | 2017 | 88 | 0.140 |
Why?
|
| Antibody Formation | 2 | 2015 | 256 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2022 | 2021 | 0.140 |
Why?
|
| Heart | 1 | 2022 | 726 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 2041 | 0.140 |
Why?
|
| DNA, Viral | 2 | 2009 | 477 | 0.140 |
Why?
|
| Brain | 1 | 2008 | 2943 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 1294 | 0.130 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12087 | 0.130 |
Why?
|
| Aged, 80 and over | 3 | 2022 | 6359 | 0.130 |
Why?
|
| Serpins | 1 | 2015 | 27 | 0.130 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 72 | 0.130 |
Why?
|
| Prognosis | 2 | 2021 | 4490 | 0.120 |
Why?
|
| Heart Diseases | 1 | 2020 | 483 | 0.120 |
Why?
|
| Myocardium | 1 | 2020 | 982 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2015 | 218 | 0.120 |
Why?
|
| Factor VIII | 2 | 2012 | 45 | 0.120 |
Why?
|
| Base Sequence | 2 | 2009 | 3093 | 0.110 |
Why?
|
| Survival Analysis | 1 | 2017 | 1470 | 0.110 |
Why?
|
| Antibodies, Neutralizing | 1 | 2017 | 459 | 0.110 |
Why?
|
| Bone and Bones | 1 | 2015 | 262 | 0.110 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2015 | 148 | 0.110 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2013 | 12 | 0.110 |
Why?
|
| Cell Line | 2 | 2010 | 2779 | 0.100 |
Why?
|
| Capsid | 1 | 2012 | 142 | 0.100 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 333 | 0.100 |
Why?
|
| Tomography | 2 | 2022 | 41 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2012 | 170 | 0.090 |
Why?
|
| Hemophilia A | 1 | 2011 | 20 | 0.090 |
Why?
|
| Immunologic Factors | 1 | 2012 | 179 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2015 | 381 | 0.090 |
Why?
|
| Epigenomics | 1 | 2011 | 162 | 0.090 |
Why?
|
| Genome, Viral | 1 | 2011 | 171 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 467 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2010 | 61 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2010 | 143 | 0.080 |
Why?
|
| Antigen-Presenting Cells | 1 | 2010 | 118 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 456 | 0.080 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 23 | 0.080 |
Why?
|
| Th1 Cells | 1 | 2010 | 152 | 0.080 |
Why?
|
| Spleen | 1 | 2010 | 272 | 0.080 |
Why?
|
| Cell Adhesion | 1 | 2010 | 321 | 0.080 |
Why?
|
| Middle Aged | 4 | 2022 | 25931 | 0.080 |
Why?
|
| Apoptosis | 1 | 2015 | 1783 | 0.080 |
Why?
|
| Interferon-beta | 1 | 2008 | 50 | 0.080 |
Why?
|
| Corpus Striatum | 1 | 2008 | 89 | 0.080 |
Why?
|
| Bone Marrow | 1 | 2010 | 322 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2008 | 74 | 0.080 |
Why?
|
| Aorta | 2 | 2022 | 540 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 815 | 0.070 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2021 | 78 | 0.070 |
Why?
|
| Cells, Cultured | 2 | 2012 | 3050 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2024 | 518 | 0.070 |
Why?
|
| Interferon-gamma | 1 | 2010 | 511 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2010 | 1102 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 1442 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 804 | 0.070 |
Why?
|
| CD11b Antigen | 1 | 2007 | 37 | 0.070 |
Why?
|
| Vero Cells | 1 | 2007 | 111 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 1063 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2013 | 1267 | 0.070 |
Why?
|
| Macrophages | 1 | 2010 | 607 | 0.070 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 939 | 0.070 |
Why?
|
| Luciferases | 1 | 2006 | 137 | 0.060 |
Why?
|
| Heart Ventricles | 2 | 2022 | 767 | 0.060 |
Why?
|
| Genes, Viral | 1 | 2006 | 183 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 571 | 0.060 |
Why?
|
| Gene Amplification | 1 | 2006 | 228 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1586 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 2024 | 42 | 0.060 |
Why?
|
| Salmonella Infections | 1 | 2024 | 31 | 0.060 |
Why?
|
| Enteric Nervous System | 1 | 2024 | 39 | 0.060 |
Why?
|
| Zygote | 1 | 2024 | 25 | 0.060 |
Why?
|
| Chick Embryo | 1 | 2024 | 132 | 0.060 |
Why?
|
| Kinetics | 1 | 2006 | 1313 | 0.060 |
Why?
|
| Oligopeptides | 1 | 2004 | 118 | 0.060 |
Why?
|
| Glioma | 1 | 2008 | 491 | 0.060 |
Why?
|
| Morula | 1 | 2023 | 1 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2024 | 263 | 0.050 |
Why?
|
| Myeloid Cells | 1 | 2023 | 98 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2023 | 110 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 1 | 2024 | 350 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 143 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2013 | 2577 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 2533 | 0.050 |
Why?
|
| Gene Editing | 1 | 2024 | 186 | 0.050 |
Why?
|
| Lymphocytes | 1 | 2023 | 403 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2023 | 420 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2024 | 250 | 0.050 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 469 | 0.050 |
Why?
|
| Time Factors | 2 | 2012 | 6198 | 0.050 |
Why?
|
| Embryonic Development | 1 | 2023 | 208 | 0.050 |
Why?
|
| Patient-Specific Modeling | 1 | 2020 | 7 | 0.040 |
Why?
|
| History, 21st Century | 1 | 2021 | 272 | 0.040 |
Why?
|
| Flecainide | 1 | 2019 | 22 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2024 | 765 | 0.040 |
Why?
|
| Mitral Valve | 1 | 2021 | 246 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 1002 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2021 | 384 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 1675 | 0.040 |
Why?
|
| Virus Replication | 2 | 2015 | 600 | 0.040 |
Why?
|
| Models, Cardiovascular | 1 | 2020 | 180 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2023 | 980 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1915 | 0.030 |
Why?
|
| 1-Carboxyglutamic Acid | 1 | 2015 | 2 | 0.030 |
Why?
|
| Alkaline Phosphatase | 1 | 2015 | 96 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2015 | 48 | 0.030 |
Why?
|
| Tacrolimus Binding Protein 1A | 1 | 2015 | 20 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 110 | 0.030 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2015 | 49 | 0.030 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 75 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2015 | 75 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2393 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 2105 | 0.030 |
Why?
|
| Electrocardiography | 1 | 2019 | 961 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 619 | 0.030 |
Why?
|
| Bone Density | 1 | 2015 | 312 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2837 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 739 | 0.030 |
Why?
|
| Mice, Inbred mdx | 1 | 2012 | 40 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2015 | 396 | 0.020 |
Why?
|
| Antigens | 1 | 2012 | 156 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2012 | 318 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 771 | 0.020 |
Why?
|
| Immunity, Humoral | 1 | 2012 | 69 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2012 | 423 | 0.020 |
Why?
|
| Homeostasis | 1 | 2015 | 681 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2011 | 118 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2011 | 19 | 0.020 |
Why?
|
| Drug Tolerance | 1 | 2011 | 40 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 193 | 0.020 |
Why?
|
| Antibodies | 1 | 2012 | 370 | 0.020 |
Why?
|
| Adjuvants, Immunologic | 1 | 2012 | 376 | 0.020 |
Why?
|
| Interferon beta-1a | 1 | 2008 | 18 | 0.020 |
Why?
|
| Butyrates | 1 | 2008 | 34 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 867 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2008 | 240 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2008 | 165 | 0.020 |
Why?
|
| Risk Factors | 1 | 2021 | 9974 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2008 | 142 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 4221 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 1148 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 4263 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 1390 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 5773 | 0.010 |
Why?
|
| Melanoma | 1 | 2008 | 836 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 28980 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2008 | 1212 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2011 | 8070 | 0.010 |
Why?
|